IFNA1 and Interstitial pneumonitis: Furthermore, there is the added complication, as discussed above, that HCV will lead to increased IP10 (and potentially ET-1) levels due to host IFN release, thus impeding the use of IP10 as biomarker for interstitial pneumonitis.